Displaying 1 - 5 of 5
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms
Blood cancer ambassador featured in Canadian Blood Services video
Updated:
Adam, of Toronto, is a blood and stem cell recipient who was diagnosed with leukemia two days after finding out he was going to become a father.
Advocacy, Partners, Volunteers
The role of pharmacists in supporting access to novel cancer treatments
Updated:
The Leukemia & Lymphoma Society of Canada were honoured to be invited to speak at the Canadian Association of Pharmacy in Oncology (CAPhO) in Moncton, New Brunswick this month.
Advocacy, Events, Partners
Canadians are ‘dying to be a priority’ in accessing cancer treatments: Open letter to the Premiers
Updated:
LLSC is at the frontlines in advocating for more timely, equitable cancer treatment access, and this week this issue was elevated publicly in light of a meeting of Canada’s premiers (a group called Council of Federation).
Advocacy, Events, Media Mentions
Line Up for Change in access to cancer care
Updated:
Christina Sit of The Leukemia & Lymphoma Society of Canada, and a co-chair of Cancer Action Now alliance, speaks with CityNews Toronto reporter about why she and other patient advocacy groups and cancer survivors are at Queen's Park on Nov 18, 2024 to "Line up for…
Advocacy, Events, Media Mentions, Partners